Evaluation of The Catalytic Role of Mumbai Project with Regards to Policy Changes

India has the highest burden of tuberculosis (TB) and multi-drug resistant TB  in the world with an estimated  2.6  million  people  with  TB  and  124,000 people  with  drug-resistant  (DR-TB) or  multi-drug resistant   TB   (MDR-TB)   in   2019. High   population density,  over-crowded  housing  and  inadequate access to safe water all contribute to the city’s high TB burden. The  MSF-OCB  Mumbai   Project   aims   to   improve outcomes  of  patients  with  DRTB  within targeted areas/facilities   within   Mumbai,   India,   working   in collaboration  with  the  Public  Health  Department  of Greater Mumbai and the National TB programme. By providing DRTB patients with appropriate treatment and support, the project aimed to reduce DRTB-related mortality and morbidity. Through these interventions, the project  ultimately aimed to demonstrate  an  effective  and  replicable  model  of care   for   DRTB   patients   which   would   influence relevant policies at national and global level, and thus achieve  improved  results  for  patients  within  and beyond the project area.